Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

18.03
Delayed Data
As of Sep 26
 -0.72 / -3.84%
Today’s Change
9.92
Today|||52-Week Range
19.98
+7.00%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 19.50, with a high estimate of 25.00 and a low estimate of 18.00. The median estimate represents a +8.15% increase from the last price of 18.03.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.34
Sales
$32.1M
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.36%
 
 
 
 
 
 
Growthannually -75.68%
 
 
 
 
 
 

Sales

Growthquarterly -2.02%
 
 
 
 
 
 
Growthannually -27.93%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.